Neisseria gonorrhoeae
Revision as of 07:57, 4 March 2014 by Rossdonaldson1 (talk | contribs)
Background
- Commonly known as gonorrhea
- Fastidious gram-negative cocci
Clinical Features
Differential Diagnosis
Workup
Management
- Proctitis
- Epididymitis
- Infectious Tenosynovitis
- Septic Arthritis (General)
- Orchitis
- Gonorrheal Conjunctivitis
Disposition
Antibiotic Sensitivities[1]
| Antibiotics | ' | N. gonorrhoeae |
| Penicillins | Penicillin G | 0 |
| Penicillin V | 0 | |
| Anti-Staphylocccal Penicillins | Methicillin | 0 |
| Nafcillin/Oxacillin | 0 | |
| Cloxacillin/Diclox. | 0 | |
| Amino-Penicillins | AMP/Amox | 0 |
| Amox/Clav | + | |
| AMP-Sulb | + | |
| Anti-Pseudomonal Penicillins | Ticarcillin | + |
| Ticar-Clav | + | |
| Pip-Taxo | + | |
| Carbapenems | Piperacillin | + |
| Doripenem | + | |
| Ertapenem | + | |
| Imipenem | + | |
| Meropenem | + | |
| Aztreonam | + | |
| Fluroquinolones | Ciprofloxacin | +* |
| Ofloxacin | +* | |
| Pefloxacin | +* | |
| Levofloxacin | +* | |
| Moxifloxacin | +* | |
| Gemifloxacin | ||
| Gatifloxacin | +* | |
| 1st G Cephalosporin | Cefazolin | + |
| 2nd G. Cephalosporin | Cefotetan | +/- |
| Cefoxitin | +/- | |
| Cefuroxime | +/- | |
| 3rd/4th G. Cephalosporin | CefoTAXime | +/- |
| Cefizoxime | +/- | |
| CefTRIAXone | + | |
| Ceftobiprole | + | |
| Ceftaroline | + | |
| CefTAZidime | +/- | |
| Cefepime | + | |
| Oral 1st G. Cephalosporin | Cefadroxil | 0 |
| Cephalexin | 0 | |
| Oral 2nd G. Cephalosporin | Cefaclor/Loracarbef | +/- |
| Cefproxil | +/- | |
| Cefuroxime axetil | +/- | |
| Oral 3rd G. Cephalosporin | Cefixime | + |
| Ceftibuten | +/- | |
| Cefpodox/Cefdinir/Cefditoren | + | |
| Aminoglycosides | Gentamicin | 0 |
| Tobramycin | 0 | |
| Amikacin | 0 | |
| Chloramphenicol | + | |
| Clindamycin | 0 | |
| Macrolides | Erythromycin | +/- |
| Azithromycin | +/- | |
| Clarithromycin | +/- | |
| Ketolide | Telithromycin | + |
| Tetracyclines | Doxycycline | +/- |
| Minocycline | +/- | |
| Glycylcycline | Tigecycline | + |
| Glyco/Lipoclycopeptides | Vancomycin | 0 |
| Teicoplanin | 0 | |
| Telavancin | 0 | |
| Fusidic Acid | + | |
| Trimethoprim | 0 | |
| TMP-SMX | +/- | |
| Urinary Agents | Nitrofurantoin | + |
| Fosfomycin | + | |
| Other | Rifampin | + |
| Metronidazole | 0 | |
| Quinupristin dalfoppristin | + | |
| Linezolid | ||
| Daptomycin | 0 | |
| Colistimethate | 0 |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
Sources
- ↑ Sanford Guide to Antimicrobial Therapy 2010
